4.10

1.44% -0.06

After Hours: 4.07 -0.03 -0.73%

Aurora Cannabis Inc. (ACB)

Overview News Price History Option Chain Why ACB Down? Discussions Forecast Stock Split

Aurora Cannabis Inc. stock is traded at $4.10, with a volume of 680.54K. It is down -1.44% in the last 24 hours and up +2.24% over the past month. Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Previous Close:

$4.16

Open:

$4.13

24h Volume:

680.54K

Relative Volume:

0.52

Market Cap:

$259.57M

Revenue:

$267.06M

Net Income/Loss:

$-69.17M

P/E Ratio:

-3.6264

EPS:

-1.1306

Net Cash Flow:

$-22.38M

1W Performance:

+5.94%

1M Performance:

+2.24%

6M Performance:

+19.88%

1Y Performance:

-17.17%

1-Day Range:

$4.08

$4.155

1-Week Range:

$3.87

$4.30

52-Week Range:

$2.56

$6.665

Aurora Cannabis Inc. Stock (ACB) Company Profile

Name

Aurora Cannabis Inc.

Sector

Healthcare (1067)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

Address

10355 Jasper Avenue, Suite 500, Edmonton, AB

Employee

Twitter

@Aurora_MMJ

Next Earnings Date

2026-11-04

Latest SEC Filings

ACB's Discussions on Twitter

Compare ACB vs TAK, TEVA, HLN, ZTS, VTRS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACB Aurora Cannabis Inc.	4.10	259.57M	267.06M	-69.17M	-22.38M	-1.1306
TAK Takeda Pharmaceutical Co Adr	18.86	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.19	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.26	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	71.05	29.36B	9.51B	2.64B	2.14B	6.0361
VTRS Viatris Inc	17.83	20.48B	14.57B	-296.50M	1.64B	-0.259

Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-27-26	Initiated	Canaccord Genuity	Buy
Dec-11-24	Initiated	TD Cowen	Buy
Feb-09-24	Upgrade	Canaccord Genuity	Hold → Buy
Sep-21-22	Upgrade	Canaccord Genuity	Sell → Hold
Jun-24-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Jun-06-22	Upgrade	Stifel	Sell → Hold
Sep-28-21	Upgrade	MKM Partners	Sell → Neutral
Sep-03-21	Upgrade	Jefferies	Underperform → Hold
May-14-21	Upgrade	BMO Capital Markets	Underperform → Market Perform
May-14-21	Downgrade	Canaccord Genuity	Hold → Sell
May-11-21	Downgrade	CIBC	Neutral → Sector Underperform
Apr-28-21	Resumed	BofA Securities	Neutral
Feb-12-21	Downgrade	Desjardins	Hold → Sell
Feb-12-21	Downgrade	MKM Partners	Neutral → Sell
Feb-12-21	Downgrade	Needham	Hold → Underperform
Dec-18-20	Downgrade	BMO Capital Markets	Market Perform → Underperform
Nov-16-20	Downgrade	Jefferies	Hold → Underperform
Nov-11-20	Downgrade	Stifel	Hold → Sell
Oct-27-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-21-20	Upgrade	Jefferies	Underperform → Hold
Sep-08-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Jun-24-20	Upgrade	Stifel	Sell → Hold
May-22-20	Downgrade	Jefferies	Hold → Underperform
May-15-20	Upgrade	Piper Sandler	Underweight → Neutral
Feb-27-20	Downgrade	Bryan Garnier	Neutral → Sell
Feb-25-20	Initiated	Needham	Hold
Feb-24-20	Downgrade	Cowen	Outperform → Market Perform
Feb-14-20	Upgrade	MKM Partners	Sell → Neutral
Feb-07-20	Downgrade	Canaccord Genuity	Speculative Buy → Hold
Jan-10-20	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-10-20	Downgrade	Piper Sandler	Overweight → Neutral
Dec-23-19	Downgrade	Jefferies	Buy → Hold
Nov-15-19	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Nov-05-19	Initiated	Cantor Fitzgerald	Neutral
Sep-24-19	Initiated	CIBC	Neutral

View All

Aurora Cannabis Inc. Stock (ACB) Latest News

11:40 AM

Aurora Cannabis (NASDAQ:ACB) Gains on International Medical Growth While Rejecting an Unsolicited Takeover Approach - Kalkine Media

11:40 AM

07:35 AM

Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch. - AOL.com

07:35 AM

07:15 AM

Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch. - The Motley Fool

07:15 AM

Sep 25, 2026

Why Is Aurora Cannabis (NASDAQ:ACB) Fighting a Hostile Takeover? - Kalkine Media

Sep 24, 2026

Aurora Cannabis Seeks Alberta Regulator's Intervention on Curaleaf's Over-20% Share Bid Disclosure - Kalkine Media

Sep 24, 2026

Aurora challenges Curaleaf bid compliance with ASC - MMJDaily

Sep 24, 2026

Aurora Cannabis Inc. (TSX:ACB): What Is Driving the Latest Story? - Kalkine Media

Sep 24, 2026

Sep 23, 2026

Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure - The Globe and Mail

Sep 23, 2026

Aurora Cannabis files ASC application over Curaleaf hostile bid deficiencies - StreetInsider

Sep 23, 2026

Aurora Cannabis files complaint over Curaleaf takeover bid By Investing.com - Investing.com India

Sep 23, 2026